Product Information
COLESTIPOL HCL 1 GM TABLET is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $0.6579 per EA under NDC 70710146707. Its NADAC has been published 221 times since Jul 13, 2022.
FDA first approved this application on Mar 10, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
1 g/1
Manufacturer
Zydus Pharmaceuticals (USA) Inc.NDC
70710146707
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
COLESTIPOL HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA215223FDA Approved
3/10/2022
TE Code
AB
On Market Since
5/4/2022
Pharmacological Classes
Price Statistics
The NADAC for COLESTIPOL HCL 1 GM TABLET has been published 221 times since Jul 13, 2022, and over the history we have for it it has declined 11.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6579 per EA |
|---|---|
| All-time high | $0.8717 (Jul 12, 2023) |
| All-time low | $0.5635 (Nov 20, 2024) |
| 52-week high | $0.6835 |
| 52-week low | $0.6534 |
| Median price | $0.7007 |
| Average price | $0.7221 |
| Largest weekly change | -24.6% (Nov 20, 2024) |
| Weeks tracked | 221 |
| Tracking since | Jul 13, 2022 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Colestipol hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Zydus Pharmaceuticals (USA) Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Colestipol hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Bile Acid Sequestrant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of COLESTIPOL HCL 1 GM TABLET?
The current National Average Drug Acquisition Cost (NADAC) for COLESTIPOL HCL 1 GM TABLET, manufactured by Zydus Pharmaceuticals (USA) Inc., is $0.6579 per EA (NDC 70710146707), effective Sep 30, 2026.
How has the price of COLESTIPOL HCL 1 GM TABLET changed over time?
Over the history we have for it, the NADAC for COLESTIPOL HCL 1 GM TABLET has declined 11.5%. It has been tracked across 221 weekly CMS publications since Jul 13, 2022.
What are the highest and lowest recorded NADAC prices for COLESTIPOL HCL 1 GM TABLET?
Since Jul 13, 2022, the NADAC for COLESTIPOL HCL 1 GM TABLET has ranged from a low of $0.5635 (Nov 20, 2024) to a high of $0.8717 (Jul 12, 2023), with a median of $0.7007 per EA.
Are there cheaper alternatives to COLESTIPOL HCL 1 GM TABLET?
No other NADAC-published product currently shares the active ingredient and strength of COLESTIPOL HCL 1 GM TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures COLESTIPOL HCL 1 GM TABLET?
COLESTIPOL HCL 1 GM TABLET (NDC 70710146707) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.